bivalirudin

Generic: bivalirudin

Labeler: eugia us llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bivalirudin
Generic Name bivalirudin
Labeler eugia us llc
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

bivalirudin 250 mg/1

Manufacturer
Eugia US LLC

Identifiers & Regulatory

Product NDC 55150-210
Product ID 55150-210_eb82831b-a234-4818-bbf2-e75e45647b77
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205962
Listing Expiration 2026-12-31
Marketing Start 2018-07-27

Pharmacologic Class

Established (EPC)
anti-coagulant [epc] direct thrombin inhibitor [epc]
Mechanism of Action
thrombin inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55150210
Hyphenated Format 55150-210

Supplemental Identifiers

RxCUI
308769
UPC
0355150210107
UNII
TN9BEX005G
NUI
N0000175980 N0000175518 N0000009963

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bivalirudin (source: ndc)
Generic Name bivalirudin (source: ndc)
Application Number ANDA205962 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-210-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

55150-210-10 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-210-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Ingredients (1)

bivalirudin (250 mg/1)

Linked Drug Pages (1)

BIVALIRUDIN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "eb82831b-a234-4818-bbf2-e75e45647b77", "openfda": {"nui": ["N0000175980", "N0000175518", "N0000009963"], "upc": ["0355150210107"], "unii": ["TN9BEX005G"], "rxcui": ["308769"], "spl_set_id": ["e574d04f-67b4-4a84-9d66-8c2d54f95120"], "pharm_class_epc": ["Anti-coagulant [EPC]", "Direct Thrombin Inhibitor [EPC]"], "pharm_class_moa": ["Thrombin Inhibitors [MoA]"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (55150-210-10)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-210-10", "marketing_start_date": "20180727"}], "brand_name": "BIVALIRUDIN", "product_id": "55150-210_eb82831b-a234-4818-bbf2-e75e45647b77", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Anti-coagulant [EPC]", "Direct Thrombin Inhibitor [EPC]", "Thrombin Inhibitors [MoA]"], "product_ndc": "55150-210", "generic_name": "BIVALIRUDIN", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BIVALIRUDIN", "active_ingredients": [{"name": "BIVALIRUDIN", "strength": "250 mg/1"}], "application_number": "ANDA205962", "marketing_category": "ANDA", "marketing_start_date": "20180727", "listing_expiration_date": "20261231"}